Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
Guidelines
MIRAGE
Alliance of Genome Resources

Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.

Source Last Updated
Alliance of Genome Resources January 28, 2025
Displaying entries 13226 - 13250 of 14279 in total
Disease ID Disease Name Alliance of Genome Resources ID Species Gene ID Gene Symbol FlyGlycoDB Evidence ▲ References
DOID:3458 breast adenocarcinoma HGNC:1100 Homo sapiens (human) 672 BRCA1 mutant phenotype evidence used in manual assertion
  • PMID:8589721
DOID:0070355 overactive bladder syndrome RGD:620401 Rattus norvegicus (Norway rat) 81509 Bdkrb1 mutant phenotype evidence used in manual assertion
  • PMID:15576455
DOID:1307 dementia HGNC:5006 Homo sapiens (human) 3156 HMGCR mutant phenotype evidence used in manual assertion
  • PMID:17640385
DOID:14503 neuronal ceroid lipofuscinosis WB:WBGene00004092 Caenorhabditis elegans 191744 ppt-1 mutant phenotype evidence used in manual assertion
  • PMID:15672447
DOID:1909 melanoma HGNC:21686 Homo sapiens (human) 8635 RNASET2 mutant phenotype evidence used in manual assertion
  • PMID:27014725
DOID:684 hepatocellular carcinoma HGNC:4004 Homo sapiens (human) 8880 FUBP1 mutant phenotype evidence used in manual assertion
  • PMID:19637194
DOID:8634 prostate carcinoma in situ HGNC:2594 Homo sapiens (human) 1588 CYP19A1 mutant phenotype evidence used in manual assertion
  • PMID:19700748
DOID:4450 renal cell carcinoma HGNC:8590 Homo sapiens (human) 5058 PAK1 mutant phenotype evidence used in manual assertion
  • PMID:17621631
DOID:2921 glomerulonephritis RGD:61897 Rattus norvegicus (Norway rat) 58949 Ptafr mutant phenotype evidence used in manual assertion
  • PMID:1668710
DOID:224 transient cerebral ischemia HGNC:8824 Homo sapiens (human) 5176 SERPINF1 mutant phenotype evidence used in manual assertion
  • PMID:18624913
DOID:3908 lung non-small cell carcinoma HGNC:3148 Homo sapiens (human) 1890 TYMP mutant phenotype evidence used in manual assertion
  • PMID:19671868
DOID:2749 glycogen storage disease Ia HGNC:4056 Homo sapiens (human) 2538 G6PC1 mutant phenotype evidence used in manual assertion
  • PMID:20389290
DOID:10283 prostate cancer HGNC:3353 Homo sapiens (human) 2026 ENO2 mutant phenotype evidence used in manual assertion
  • PMID:15239127
DOID:10763 hypertension HGNC:484 Homo sapiens (human) 284 ANGPT1 mutant phenotype evidence used in manual assertion
  • PMID:18285514
DOID:3070 high grade glioma HGNC:2705 Homo sapiens (human) 1634 DCN mutant phenotype evidence used in manual assertion
  • PMID:15475879
DOID:7188 autoimmune thyroiditis HGNC:4947 Homo sapiens (human) 3122 HLA-DRA mutant phenotype evidence used in manual assertion
  • PMID:12126634
DOID:0081312 T-cell non-Hodgkin lymphoma HGNC:5392 Homo sapiens (human) 8870 IER3 mutant phenotype evidence used in manual assertion
  • PMID:14534530
DOID:1936 atherosclerosis RGD:2069 Rattus norvegicus (Norway rat) 24179 Agt mutant phenotype evidence used in manual assertion
  • PMID:22977667
DOID:5844 myocardial infarction HGNC:9052 Homo sapiens (human) 5328 PLAU mutant phenotype evidence used in manual assertion
  • PMID:17653104
DOID:11054 urinary bladder cancer HGNC:11772 Homo sapiens (human) 7046 TGFBR1 mutant phenotype evidence used in manual assertion
  • PMID:9363992
DOID:1210 optic neuritis HGNC:4948 Homo sapiens (human) 3123 HLA-DRB1 mutant phenotype evidence used in manual assertion
  • PMID:22167100
DOID:2548 reflex epilepsy RGD:628841 Rattus norvegicus (Norway rat) 83810 Trpv1 mutant phenotype evidence used in manual assertion
  • PMID:29105300
DOID:2527 nephrosis RGD:2493 Rattus norvegicus (Norway rat) 24310 Ace mutant phenotype evidence used in manual assertion
  • PMID:8665777
DOID:2841 asthma HGNC:17451 Homo sapiens (human) 10800 CYSLTR1 mutant phenotype evidence used in manual assertion
  • PMID:11591188
  • PMID:8087328
DOID:0060730 torsion dystonia 1 WB:WBGene00003870 Caenorhabditis elegans 174433 ooc-5 mutant phenotype evidence used in manual assertion
  • PMID:11714689
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback

Click here to visit the beta site.

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.4.0

Last updated: December 8, 2025